Canada Spends Logo

Explore our Budget 2026 analysis

Grant: Master's Award: Canada Graduate Scholarships

Université de Sherbrooke

$17,500.00

Upregulated H/ACA snoRNA in high grade ovarian cancer promote cell survival and proliferation ?

FY 2018-19

Summary
SnoRNAs are small RNAs functioning in the nucleolus of eukaryotic cells. They are separated in two groups (H/ACA box and C/D box) which guide different modifications on the ribosomal RNA. Several previous studies have identified snoRNAs as being dysregulated in cancers. They are promising biomarkers because they are stable and are detectable in blood. Ovarian cancer is one of the deadliest cancers in the female reproductive system, lack of particular symptoms and late diagnosis, results in lower success of conventional treatments. There is a need to identify biomarkers that would permit earlier detection of high grade ovarian cancers, which are very aggressive as compared to borderline tumors which have a higher treatment efficiency. Previous experiments carried out in our laboratory confirmed that the expression of snoRNA H/ACA box is upregulated and the expression of snoRNA C/D box is downregulated in high grade ovarian cancers as compared to serous borderline tumors. Two snoRNAs (SNORA19 & SNORA81) were therefore selected as being able to differentiate between high grade and borderline ovarian cancer. In order to understand if the cancer cells phenotype is affected by these snoRNAs, their expression was knockdown in a high grade ovarian cancer cell line. Reducing the expression of SNORA19 and SNORA81 led to a decreased cell survival and proliferation in ovarian cancer cells. More experiments are necessary to specifically understand the role of these snoRNAs and why their expression is increased in high grade ovarian cancer as compared to borderline tumors. More importantly understanding how these snoRNAs are providing cancer cells a resistance to cell death could offer new strategies for early diagnosis of this cancer.
Program
Master's Award: Canada Graduate Scholarships
Location
Quebec, Canada
Recipient Type
Academia
Type
Grant
Source
CIHR Funding Decisions Database

As published

Id
411239
Name
Faucher-Giguère Laurence
Region
Québec
Country
Canada
Orgtype
Institution Paid; Research Institution
Prcname2
Special Cases - Awards Programs
Projecttitle
Upregulated H/ACA snoRNA in high grade ovarian cancer promote cell survival and proliferation ?
Programtype2
Studentship Programs
Orgnameinp2
Université de Sherbrooke
Cihramount2
$17,500
Cihrequipment2
$0
Programname2
Master's Award: Canada Graduate Scholarships
Keyworddelim
Biomarkers; High Grade Ovarian Cancer; Ribosomes Biogenesis; Rna Modifications; Snorna
Abstract
SnoRNAs are small RNAs functioning in the nucleolus of eukaryotic cells. They are separated in two groups (H/ACA box and C/D box) which guide different modifications on the ribosomal RNA. Several previous studies have identified snoRNAs as being dysregulated in cancers. They are promising biomarkers because they are stable and are detectable in blood. Ovarian cancer is one of the deadliest cancers in the female reproductive system, lack of particular symptoms and late diagnosis, results in lower success of conventional treatments. There is a need to identify biomarkers that would permit earlier detection of high grade ovarian cancers, which are very aggressive as compared to borderline tumors which have a higher treatment efficiency. Previous experiments carried out in our laboratory confirmed that the expression of snoRNA H/ACA box is upregulated and the expression of snoRNA C/D box is downregulated in high grade ovarian cancers as compared to serous borderline tumors. Two snoRNAs (SNORA19 & SNORA81) were therefore selected as being able to differentiate between high grade and borderline ovarian cancer. In order to understand if the cancer cells phenotype is affected by these snoRNAs, their expression was knockdown in a high grade ovarian cancer cell line. Reducing the expression of SNORA19 and SNORA81 led to a decreased cell survival and proliferation in ovarian cancer cells. More experiments are necessary to specifically understand the role of these snoRNAs and why their expression is increased in high grade ovarian cancer as compared to borderline tumors. More importantly understanding how these snoRNAs are providing cancer cells a resistance to cell death could offer new strategies for early diagnosis of this cancer.
Competitiondate
201812
Approvedterm2
1 yr 0 mth
Pinamesdelim
Faucher-Giguère, Laurence
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $17,500~ $0~
Université de Sherbrooke - $17,500 Grant (2018-19) | Canada Spends